IE921212A1
(en)
*
|
1991-04-19 |
1992-10-21 |
Affinity Biotech Inc |
Convertible microemulsion formulations
|
US5688761A
(en)
*
|
1991-04-19 |
1997-11-18 |
Lds Technologies, Inc. |
Convertible microemulsion formulations
|
JPH08502492A
(ja)
*
|
1992-10-16 |
1996-03-19 |
スミスクライン・ビーチャム・コーポレイション |
治療用ミクロエマルジョン
|
EP0671937A4
(de)
*
|
1992-10-16 |
1996-09-18 |
Smithkline Beecham Corp |
Pharmazeutische emulsionszusammensetzungen.
|
WO1994008603A1
(en)
*
|
1992-10-16 |
1994-04-28 |
Smithkline Beecham Corporation |
Compositions
|
JPH08504759A
(ja)
*
|
1992-10-16 |
1996-05-21 |
アイビーエイエイチ・インコーポレーテッド |
反転性マイクロエマルション組成物
|
DK17093D0
(da)
*
|
1993-02-15 |
1993-02-15 |
Lyfjathroun H F |
Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
|
JPH06279228A
(ja)
*
|
1993-03-30 |
1994-10-04 |
Kao Corp |
発泡性組成物
|
TW438603B
(en)
*
|
1993-04-19 |
2001-06-07 |
Advanced Skin Res Kenkyusho Kk |
Microemulsion preparation containing peptide pharmaceuticals
|
US6191105B1
(en)
*
|
1993-05-10 |
2001-02-20 |
Protein Delivery, Inc. |
Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
|
US5514670A
(en)
*
|
1993-08-13 |
1996-05-07 |
Pharmos Corporation |
Submicron emulsions for delivery of peptides
|
US5744155A
(en)
*
|
1993-08-13 |
1998-04-28 |
Friedman; Doron |
Bioadhesive emulsion preparations for enhanced drug delivery
|
AU7706494A
(en)
*
|
1993-09-29 |
1995-04-18 |
Technobiochip |
Protein thin films and compositions for use in their preparation
|
DE4335045A1
(de)
*
|
1993-10-14 |
1995-04-20 |
Henkel Kgaa |
Fließfähiges Emulsionskonzentrat
|
WO1995014037A1
(en)
*
|
1993-11-17 |
1995-05-26 |
Ibah, Inc. |
Transparent liquid for encapsulated drug delivery
|
WO1995025504A1
(en)
*
|
1994-03-18 |
1995-09-28 |
Pharmavene, Inc. |
Emulsified drug delivery systems
|
US5672358A
(en)
*
|
1994-06-21 |
1997-09-30 |
Ascent Pharmaceuticals, Inc. |
Controlled release aqueous emulsion
|
GB9412394D0
(en)
*
|
1994-06-21 |
1994-08-10 |
Danbiosyst Uk |
Colonic drug delivery composition
|
JPH0827018A
(ja)
*
|
1994-07-22 |
1996-01-30 |
Sanwa Kagaku Kenkyusho Co Ltd |
生理活性ペプチド又は蛋白質を含有する薬剤組成物
|
US5707641A
(en)
*
|
1994-10-13 |
1998-01-13 |
Pharmaderm Research & Development Ltd. |
Formulations comprising therapeutically-active proteins or polypeptides
|
AU698317B2
(en)
|
1995-02-25 |
1998-10-29 |
Cancer Research Technology Limited |
Transgenic animals as model of psoriasis
|
DE19509079A1
(de)
*
|
1995-03-15 |
1996-09-19 |
Beiersdorf Ag |
Kosmetische oder dermatologische Mikroemulsionen
|
US6689370B1
(en)
|
1995-04-20 |
2004-02-10 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
FR2733151B1
(fr)
*
|
1995-04-20 |
1997-05-23 |
Seppic Sa |
Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
|
US6117432A
(en)
*
|
1995-04-20 |
2000-09-12 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
US6008228A
(en)
*
|
1995-06-06 |
1999-12-28 |
Hoffman-La Roche Inc. |
Pharmaceutical compositions containing proteinase inhibitors
|
US5766636A
(en)
*
|
1995-09-06 |
1998-06-16 |
Natura, Inc. |
Edible, low calorie compositions of a carrier and an active ingredient and methods for preparation thereof
|
SE9503143D0
(sv)
|
1995-09-12 |
1995-09-12 |
Astra Ab |
New preparation
|
EP0781559B1
(de)
*
|
1995-11-30 |
2007-02-07 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Öladjuvierter Impfstoff und Verfahren zu seiner Herstellung
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
WO1997029773A1
(fr)
*
|
1996-02-13 |
1997-08-21 |
The Nisshin Oil Mills, Ltd. |
Emulsion et poudre renfermant un vaccin et destinees a une administration orale, et procede de production associe
|
US6245349B1
(en)
*
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
WO1997035560A1
(en)
|
1996-03-28 |
1997-10-02 |
The Board Of Trustees Of The University Of Illinois |
Materials and methods for making improved echogenic liposome compositions
|
US5726154A
(en)
*
|
1996-06-28 |
1998-03-10 |
University Of Utah Research Foundation |
Stabilization and oral delivery of calcitonin
|
ES2202554T5
(es)
*
|
1996-08-30 |
2011-11-28 |
Ajinomoto Co., Inc. |
Composición de lavado.
|
AU4491697A
(en)
*
|
1996-09-27 |
1998-04-17 |
Trega Biosciences, Inc. |
Compositions of therapeutic agents suitable for oral administration
|
SE511313C2
(sv)
|
1997-01-13 |
1999-09-06 |
Gs Dev Ab |
Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US7585645B2
(en)
*
|
1997-05-27 |
2009-09-08 |
Sembiosys Genetics Inc. |
Thioredoxin and thioredoxin reductase containing oil body based products
|
IS4518A
(is)
*
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
US6217886B1
(en)
|
1997-07-14 |
2001-04-17 |
The Board Of Trustees Of The University Of Illinois |
Materials and methods for making improved micelle compositions
|
FR2767064B1
(fr)
*
|
1997-08-07 |
1999-11-12 |
Centre Nat Rech Scient |
Procede de liberation d'un principe actif contenu dans une emulsion multiple
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6024786A
(en)
*
|
1997-10-30 |
2000-02-15 |
Hewlett-Packard Company |
Stable compositions of nano-particulate unmodified pigments and insoluble colorants in aqueous microemulsions, and principle of stability and methods of formation thereof
|
US20020031513A1
(en)
*
|
1997-11-24 |
2002-03-14 |
Shamir Leibovitz |
Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
|
US6221378B1
(en)
|
1998-02-10 |
2001-04-24 |
Generex Pharmaceuticals Incorporated |
Mixed micellar delivery system and method of preparation
|
US7070799B1
(en)
*
|
1998-02-10 |
2006-07-04 |
Generex Pharmaceuticals, Inc. |
Method for administering insulin to the buccal region
|
US6017545A
(en)
*
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
DE19806889A1
(de)
*
|
1998-02-19 |
1999-08-26 |
Beiersdorf Ag |
Verwendung von Acyl-Carnitin
|
US20030180368A1
(en)
*
|
1998-03-14 |
2003-09-25 |
Cenes Drug Delivery Limited |
Production of microparticles
|
TWI241915B
(en)
|
1998-05-11 |
2005-10-21 |
Ciba Sc Holding Ag |
A method of preparing a pharmaceutical end formulation using a nanodispersion
|
US8466134B1
(en)
|
1998-06-26 |
2013-06-18 |
Athena Neurosciences, Inc. |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
US6241969B1
(en)
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
FR2780644B1
(fr)
*
|
1998-07-03 |
2001-07-20 |
Oreal |
Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse et d'une phase aqueuse, stabilisee a l'aide de particules de gel cubique
|
EP0976394A1
(de)
*
|
1998-07-30 |
2000-02-02 |
Biosearch Italia S.p.A. |
Neue injizierbare Formulierungen
|
ATE462417T1
(de)
|
1998-08-13 |
2010-04-15 |
Cima Labs Inc |
Microemulsionen als feste dosisformen zur oralen verabreichung
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
DE19859427A1
(de)
*
|
1998-12-22 |
2000-06-29 |
Beiersdorf Ag |
Kosmetische oder pharmazeutische lecithinhaltige Gele oder niedrigviskose, lecithinhaltige O/W-Mikroemulsionen
|
GB9903547D0
(en)
*
|
1999-02-16 |
1999-04-07 |
Novartis Ag |
Organic compounds
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
US20070148228A1
(en)
*
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
US8119159B2
(en)
*
|
1999-02-22 |
2012-02-21 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
EP1064934A1
(de)
|
1999-06-30 |
2001-01-03 |
Applied Research Systems ARS Holding N.V. |
Gefriergetrocknete GRF-enthaltende Arzneimittel
|
US6982281B1
(en)
*
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
GB0005736D0
(en)
*
|
2000-03-09 |
2000-05-03 |
G C Hahn Co Ltd |
Low fat edible emulsions
|
DE10015463B4
(de)
*
|
2000-03-29 |
2008-01-10 |
Heide, Peter Edgar, Dr. |
Creme in Form einer überwässerten Wasser-in-Öl-Emulsion
|
EP1296709A1
(de)
*
|
2000-06-21 |
2003-04-02 |
Ferring BV |
Solubilisierte proteinimpfstoffe
|
US20030148924A1
(en)
*
|
2002-07-09 |
2003-08-07 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions of healing wounds
|
JP2004536018A
(ja)
|
2000-07-31 |
2004-12-02 |
バル・イラン・ユニバーシティ |
創傷治療のための方法および薬学的組成物
|
US20100129332A1
(en)
*
|
2000-07-31 |
2010-05-27 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions for healing wounds
|
US20060258562A1
(en)
*
|
2000-07-31 |
2006-11-16 |
Healor Ltd. |
Methods and pharmaceutical compositions for healing wounds
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
US6582682B2
(en)
*
|
2000-10-30 |
2003-06-24 |
Noville, Inc. |
Oral care compositions comprising stabilized chlorine dioxide
|
CN1406131A
(zh)
*
|
2000-12-25 |
2003-03-26 |
株式会社资生堂 |
活化交感神经的香料组合物
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6692771B2
(en)
*
|
2001-02-23 |
2004-02-17 |
Cima Labs Inc. |
Emulsions as solid dosage forms for oral administration
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
EP1528937B1
(de)
*
|
2001-06-05 |
2016-08-10 |
The Regents Of The University Of Michigan |
Nanoemulsionsvakzine
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7196059B2
(en)
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
AU2002362040A1
(en)
*
|
2001-12-03 |
2003-06-17 |
Dor Biopharma Inc. |
Reverse micelle compositions and uses thereof
|
ATE424815T1
(de)
*
|
2001-12-03 |
2009-03-15 |
Dor Biopharma Inc |
Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
|
US20050106122A1
(en)
*
|
2002-02-25 |
2005-05-19 |
Sveinbjorn Gizurarson |
Absorption enhancing agent
|
US20050124705A1
(en)
*
|
2002-03-28 |
2005-06-09 |
Beiersdorf Ag |
Cosmetic or pharmaceutical, low-viscosity oil-in-water emulsions containing phospholipids
|
EP1506035A1
(de)
*
|
2002-05-06 |
2005-02-16 |
Vectura Limited |
Auftragevorrichtung zum örtlichen verabreichen von pharmazeutischen wirkstoffen
|
WO2003105768A2
(en)
*
|
2002-06-13 |
2003-12-24 |
Nobex Corporation |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
DE10226990A1
(de)
*
|
2002-06-18 |
2004-03-18 |
Sanguibiotech Ag |
Topisch applizierbare Mikro-Emulsionen mit binärer Phasen- und Wirkstoffdifferenzierbarkeit, deren Herstellung und deren Verwendung, insbesondere zur Versorgung der Haut mit bioverfügbarem Sauerstoff
|
CA2430889A1
(en)
*
|
2002-06-19 |
2003-12-19 |
Bayer Corporation |
Stabilization of brain natriuretic peptide (bnp) in blood samples, methods and compositions related thereto
|
US6855332B2
(en)
|
2002-07-03 |
2005-02-15 |
Lyfjathroun Hf. |
Absorption promoting agent
|
US20040115226A1
(en)
*
|
2002-12-12 |
2004-06-17 |
Wenji Li |
Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
|
US20050196370A1
(en)
*
|
2003-03-18 |
2005-09-08 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
|
KR100515752B1
(ko)
*
|
2003-05-16 |
2005-09-20 |
주식회사 엘지화학 |
초임계 유체를 이용한 스티렌과 말레이미드 공중합체의제조 방법
|
US7445933B2
(en)
*
|
2003-07-16 |
2008-11-04 |
Abbott Laboratories, Inc. |
Stable calibrators or controls for measuring human natriuretic peptides
|
US7291501B2
(en)
|
2003-07-16 |
2007-11-06 |
Abbott Laboratories |
Stable compositions for measuring human natriuretic peptides
|
US7004340B2
(en)
*
|
2003-07-25 |
2006-02-28 |
Alpha Security Products, Inc. |
Bottle security device
|
RU2358753C2
(ru)
|
2003-08-07 |
2009-06-20 |
Хилор Лтд. |
Фармацевтические композиции и способы для ускорения заживления ран
|
US9259390B2
(en)
*
|
2003-08-13 |
2016-02-16 |
The University Of Houston System |
Parenteral and oral formulations of benzimidazoles
|
JP2007509954A
(ja)
|
2003-10-27 |
2007-04-19 |
ダウ コーニング コーポレーション |
局所的な適用のための徐放性の組成物及び基体へ活性な作用薬を配送する方法
|
CA2537029C
(en)
*
|
2003-11-26 |
2013-03-12 |
Likan Liang |
Micellar systems useful for delivery of lipophilic or hydrophobic compounds
|
PE20050596A1
(es)
*
|
2003-12-19 |
2005-10-18 |
Novartis Ag |
Microemulsion que comprende un inhibidor renina
|
US20050232974A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Gore Makarand P |
System and a method for pharmaceutical dosage preparation using jettable microemulsions
|
US20050238675A1
(en)
*
|
2004-04-26 |
2005-10-27 |
Wenjie Li |
Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
|
US7357957B2
(en)
*
|
2004-05-07 |
2008-04-15 |
Fractec Research & Development Inc. |
Spreadable food product
|
US20070093610A1
(en)
*
|
2004-05-12 |
2007-04-26 |
Kim Dong R |
Method for preparing styrene and maleimide copolymer using super critical fluid
|
NZ553263A
(en)
|
2004-07-19 |
2010-06-25 |
Biocon Ltd |
Insulin-oligomer conjugates, formulations and uses thereof
|
US20060078622A1
(en)
*
|
2004-08-13 |
2006-04-13 |
Emisphere Technologies, Inc. |
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
|
EP1799266A2
(de)
*
|
2004-09-13 |
2007-06-27 |
Bharat Serums & Vaccines Ltd. |
Stabile emulsionszusammensetzungen für die intravenöse verabreichung mit antimikrobiell erhaltender wirksamkeit
|
DE102004049574A1
(de)
|
2004-10-12 |
2006-04-20 |
Doris Dr. Barnikol-Keuten |
Arzneimittel und System zur perkutanen Arzneistoffverabreichung
|
KR101322586B1
(ko)
*
|
2005-01-19 |
2013-10-25 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
희석용 에멀젼화 조성물 및 암 백신 조성물
|
US20060205904A1
(en)
*
|
2005-03-11 |
2006-09-14 |
St Clair David J |
Oil gels of controlled distribution block copolymers and ester oils
|
KR20080009201A
(ko)
|
2005-04-15 |
2008-01-25 |
클라루스 쎄러퓨틱스, 아이엔씨. |
소수성 약물의 약물전달시스템 및 이를 포함하는 조성물
|
US8492369B2
(en)
|
2010-04-12 |
2013-07-23 |
Clarus Therapeutics Inc |
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
|
EP1906974A4
(de)
*
|
2005-07-22 |
2010-06-23 |
Univ California |
Heparinzusammensetzungen und selectin-hemmung
|
US20070042007A1
(en)
*
|
2005-08-19 |
2007-02-22 |
Joseph Schwarz |
Topical composition for delivery of salicylate esters
|
ZA200802546B
(en)
*
|
2005-08-29 |
2009-10-28 |
Healor Ltd |
Methods and compositions for prvention and treatment of diabetic and aged skin
|
DOP2006000267A
(es)
*
|
2005-11-30 |
2009-06-30 |
Colgate Palmalive Company |
Composiciones y métodos de limpieza
|
US20070243132A1
(en)
*
|
2005-12-22 |
2007-10-18 |
Apollo Life Sciences Limited |
Transdermal delivery of pharmaceutical agents
|
EP2007397B1
(de)
*
|
2006-04-07 |
2013-07-24 |
Merrion Research III Limited |
Feste orale Darreichungsform mit einem Verstärker
|
GB0623838D0
(en)
*
|
2006-11-29 |
2007-01-10 |
Malvern Cosmeceutics Ltd |
Novel compositions
|
US9918934B2
(en)
*
|
2006-12-12 |
2018-03-20 |
Edgar Joel Acosta-Zara |
Linker-based lecithin microemulsion delivery vehicles
|
US7968635B2
(en)
*
|
2006-12-28 |
2011-06-28 |
Continental Ag |
Tire compositions and components containing free-flowing filler compositions
|
FR2915101B1
(fr)
*
|
2007-04-23 |
2011-07-29 |
Fabre Pierre Dermo Cosmetique |
Composition dermatologique pour la prevention et/ou le traitement de la rosacee, de la couperose ou des peaux qui presentent des rougeurs diffuses ou des petits vaisseaux dilates
|
AU2008281374B2
(en)
*
|
2007-07-30 |
2012-05-31 |
Healor Ltd. |
Pharmaceutical composition for treating wounds and related methods
|
CN101772352B
(zh)
*
|
2007-09-27 |
2012-05-23 |
理研维他命株式会社 |
软胶囊填充用液态组合物
|
JP5156458B2
(ja)
*
|
2008-03-31 |
2013-03-06 |
理研ビタミン株式会社 |
ソフトカプセル充填用液状組成物
|
WO2009050738A2
(en)
|
2007-10-16 |
2009-04-23 |
Biocon Limited |
An orally administerable solid pharmaceutical composition and a process thereof
|
CA2711114A1
(en)
*
|
2008-01-02 |
2009-07-16 |
Kringle Pharma Inc. |
Topical compositions for the controlled delivery of proteins and peptides
|
TW200950799A
(en)
*
|
2008-05-07 |
2009-12-16 |
Merrion Res Iii Ltd |
Compositions of GnRH related compounds and processes of preparation
|
US20100004196A1
(en)
*
|
2008-06-17 |
2010-01-07 |
Hopitaux Universitaires De Geneve |
Heparan sulfate proteoglycan composition and use thereof
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
ES2601827T3
(es)
*
|
2009-02-24 |
2017-02-16 |
Arava Bio-Tech Ltd. |
Agentes antagonistas de visfatina para el tratamiento del acné y de otras afecciones
|
US20100215743A1
(en)
*
|
2009-02-25 |
2010-08-26 |
Leonard Thomas W |
Composition and drug delivery of bisphosphonates
|
AU2010292233B2
(en)
*
|
2009-09-10 |
2014-03-06 |
Boehringer Ingelheim Animal Health USA Inc. |
New vaccine formulations comprising saponin-containing adjuvants
|
EP2509583B1
(de)
*
|
2009-12-10 |
2019-05-15 |
Merck Patent GmbH |
Pharmazeutische zusammensetzung mit oligopeptiden, bevorzugt cilengitid
|
RU2012134041A
(ru)
|
2010-01-11 |
2014-02-20 |
Хилор Лтд. |
Способ лечения воспалительного заболевания и расстройства
|
BR112012016853A2
(pt)
|
2010-01-12 |
2017-10-17 |
Novo Nordisk As |
"composições farmacêuticas para administração oral de peptídeos de insulina".
|
US20110182985A1
(en)
*
|
2010-01-28 |
2011-07-28 |
Coughlan David C |
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
|
WO2011120033A1
(en)
*
|
2010-03-26 |
2011-09-29 |
Merrion Research Iii Limited |
Pharmaceutical compositions of selective factor xa inhibitors for oral administration
|
FR2964332A1
(fr)
*
|
2010-09-06 |
2012-03-09 |
Capsum |
Nanodispersions inverses stables
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
SG189845A1
(en)
|
2010-12-01 |
2013-06-28 |
Omnis Biotechnology Inc |
Thixotropic compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
CA2819234A1
(en)
|
2011-01-07 |
2012-07-12 |
Merrion Research Iii Limited |
Pharmaceutical compositions of iron for oral administration
|
GB201107630D0
(en)
*
|
2011-05-06 |
2011-06-22 |
Proxima Concepts Ltd |
Microemulsions
|
EP4088736A1
(de)
|
2011-10-25 |
2022-11-16 |
Prothena Biosciences Limited |
Humanisierte anti-amyloid-antikörper-formulierungen und verfahren
|
IN2014CH01872A
(de)
*
|
2014-04-09 |
2015-05-08 |
Nanoceutica Lab Pvt Ltd |
|
EP2946788A1
(de)
|
2014-05-23 |
2015-11-25 |
Immundiagnostik AG |
Verfahren und Zusammensetzung zur Behandlung von Herzversagen mit erhaltener Austreibungsfraktion
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
WO2016120378A1
(en)
|
2015-01-29 |
2016-08-04 |
Novo Nordisk A/S |
Tablets comprising glp-1 agonist and enteric coating
|
US9872832B2
(en)
*
|
2015-10-23 |
2018-01-23 |
LG Bionano, LLC |
Nanoemulsions having reversible continuous and dispersed phases
|
AU2017326435B2
(en)
*
|
2016-09-16 |
2021-07-22 |
Kemin Industries, Inc. |
Animal feed supplement
|
US20180147215A1
(en)
|
2016-11-28 |
2018-05-31 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
KR101786914B1
(ko)
*
|
2017-01-31 |
2017-11-15 |
주식회사 삼양사 |
피부 리프팅 또는 탄력 개선을 위한 점착성 탄력 밴드
|
CN112915916B
(zh)
*
|
2021-01-29 |
2022-05-24 |
江南大学 |
一种pH刺激响应型胆汁盐Pickering复合乳化剂
|